Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)

Recruiting N/A Interventional Study
Stroke Traumatic Brain Injury Multiple Sclerosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
48 (estimated)
Sponsor
Luzerner Kantonsspital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This feasibility study investigates the potential of hypnosis as a complementary therapy for improving attentional deficits and reducing fatigue in patients with neurological conditions such as stroke, traumatic brain injury (TBI), and multiple sclerosis (MS). These patients often experience reduced spontaneous visual exploration and impaired functional independence despite current rehabilitation …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * ICD-10 Diagnosis of stroke, TBI or MS * Admitted to the inpatient and/or outpatient in the Clinic for Neurology and Neurorehabilitation * Age 18 years old or older * Understanding the German language * Written informed consent Exclusion Criteria: \- Psychiatric disease Excl…
Contacts

Thomas Nyffeler, Prof. Dr. med.

+41412055686

thomas.nyffeler@luks.ch

CONTACT